Literature DB >> 25894287

New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.

Dorit Trudler1,2, Yuval Nash1,2, Dan Frenkel3,4.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor disturbances, appearance of Lewy bodies and dopaminergic neuronal death. The etiology of PD is unknown, although aging and neurotoxins are established risk factors. The activation of glial cells in the brain is the first defense mechanism against pathological events in neurodegenerative diseases, and neuroinflammation is suggested to play an important role in PD disease progression leading to dopaminergic neuronal degeneration. Gene mutations in several PD-related genes may affect up to 15% of the PD cases. These gene mutations can cause either loss or gain of function in their respective proteins leading to autosomal recessive and autosomal dominant PD, respectively. Most of the identified genes play a role in mitochondrial activity and integrity, and this was demonstrated mostly in neuronal cells. In this review, we aim to describe the link between PD-related genes, which are involved in mitochondrial function, and deleterious neuroinflammation.

Entities:  

Keywords:  Astrocytes; Inflammation; Microglia; PD genes

Mesh:

Year:  2015        PMID: 25894287     DOI: 10.1007/s00702-015-1399-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  140 in total

Review 1.  Mitochondrial involvement in Parkinson's disease.

Authors:  M Orth; A H V Schapira
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

Review 2.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

Review 3.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.

Authors:  Katerina Venderova; Ghassan Kabbach; Elizabeth Abdel-Messih; Yi Zhang; Robin J Parks; Yuzuru Imai; Stephan Gehrke; Johnny Ngsee; Matthew J Lavoie; Ruth S Slack; Yong Rao; Zhuohua Zhang; Bingwei Lu; M Emdadul Haque; David S Park
Journal:  Hum Mol Genet       Date:  2009-08-19       Impact factor: 6.150

5.  Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

Authors:  Wei Zhang; Shannon Dallas; Dan Zhang; Jian-Ping Guo; Hao Pang; Belinda Wilson; David S Miller; Biao Chen; Wanqin Zhang; Patrick L McGeer; Jau-Shyong Hong; Jing Zhang
Journal:  Glia       Date:  2007-08-15       Impact factor: 7.452

6.  Regulation of LRRK2 expression points to a functional role in human monocyte maturation.

Authors:  Jonathan Thévenet; Rosanna Pescini Gobert; Robertus Hooft van Huijsduijnen; Christoph Wiessner; Yves Jean Sagot
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

7.  PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.

Authors:  Wencheng Liu; Cristofol Vives-Bauza; Rebeca Acín-Peréz-; Ai Yamamoto; Yingcai Tan; Yanping Li; Jordi Magrané; Mihaela A Stavarache; Sebastian Shaffer; Simon Chang; Michael G Kaplitt; Xin-Yun Huang; M Flint Beal; Giovanni Manfredi; Chenjian Li
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

8.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

Review 9.  A mitocentric view of Parkinson's disease.

Authors:  Nele A Haelterman; Wan Hee Yoon; Hector Sandoval; Manish Jaiswal; Joshua M Shulman; Hugo J Bellen
Journal:  Annu Rev Neurosci       Date:  2014-05-05       Impact factor: 12.449

10.  PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices.

Authors:  Jun Kim; Ji-Won Byun; Insup Choi; Beomsue Kim; Hey-Kyeong Jeong; Ilo Jou; Eunhye Joe
Journal:  Exp Neurobiol       Date:  2013-03-31       Impact factor: 3.261

View more
  11 in total

1.  NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.

Authors:  Hayate Javed; Ramasamy Thangavel; Govindhasamy Pushpavathi Selvakumar; Iuliia Dubova; Noah Schwartz; Mohammad Ejaz Ahmed; Smita Zaheer; Duraisamy Kempuraj; Shankar Iyer; Asgar Zaheer; Mohammad Moshahid Khan
Journal:  Int Immunopharmacol       Date:  2020-04-04       Impact factor: 4.932

2.  Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)).

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Ranan Fattal; Sagar Pattani; Evert Yang; Smita Zaheer; Donna A Santillan; Mark K Santillan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

3.  Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Authors:  Todd Hulgan; David C Samuels; William Bush; Ronald J Ellis; Scott L Letendre; Robert K Heaton; Donald R Franklin; Peter Straub; Deborah G Murdock; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Igor Grant; Asha R Kallianpur
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 20.999

4.  Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Evert Yang; Sagar Pattani; Smita Zaheer; Donna A Santillan; Mark K Santillan; Asgar Zaheer
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder.

Authors:  C Morén; Í González-Casacuberta; J Navarro-Otano; D Juárez-Flores; D Vilas; G Garrabou; J C Milisenda; C Pont-Sunyer; M Catalán-García; M Guitart-Mampel; E Tobías; F Cardellach; F Valldeoriola; A Iranzo; E Tolosa
Journal:  Parkinsons Dis       Date:  2017-06-04

6.  European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.

Authors:  David C Samuels; Asha R Kallianpur; Ronald J Ellis; William S Bush; Scott Letendre; Donald Franklin; Igor Grant; Todd Hulgan
Journal:  Pathog Immun       Date:  2016 Fall-Winter

7.  Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.

Authors:  Tuo Liang; Zhong-Ming Qian; Ming-Dao Mu; Wing-Ho Yung; Ya Ke
Journal:  iScience       Date:  2020-06-19

8.  Butyrate regulates inflammatory cytokine expression without affecting oxidative respiration in primary astrocytes from spontaneously hypertensive rats.

Authors:  Tao Yang; Vermali Rodriguez; Wendi L Malphurs; Jordan T Schmidt; Niousha Ahmari; Colin Sumners; Christopher J Martyniuk; Jasenka Zubcevic
Journal:  Physiol Rep       Date:  2018-07

Review 9.  Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era.

Authors:  Dunhui Li; Frank L Mastaglia; Sue Fletcher; Steve D Wilton
Journal:  Med Res Rev       Date:  2020-08-06       Impact factor: 12.944

Review 10.  The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease.

Authors:  Wen Yu; Jun Ying; Xifeng Wang; Xing Liu; Tiancheng Zhao; Sungtae Yoon; Qingcui Zheng; Yang Fang; Danying Yang; Fuzhou Hua
Journal:  Front Aging Neurosci       Date:  2021-07-19       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.